image header

News Releases

News Releases

Feb 18, 2020

ALX Oncology’s ALX148 Receives Two Fast Track Designations from FDA for the Treatment of Patients with Head and Neck Squamous Cell Carcinoma and Patients with Gastric or Gastroesophageal Junction Adenocarcinoma Read more

Feb 12, 2020

ALX Oncology Announces Closing of $105 Million Series C Financing Read more

Jan 7, 2020

ALX Oncology Appoints Peter S. García as Chief Financial Officer Read more

Displaying 11 - 13 of 13